Alphabet Ventures, an Alphabet Health Group company, is a global biopharma and medtech investment company that aim to accelerate innovations. Our investment thesis focuses on science, unmet need, commercial profile and exit strategy. Equally important is global strategic planning and how opportunities can be leveraged in ecosystems across the globe.

Our investment focuses on innovations that are differentiated, address significant unmet need and ultimately deliver health to many patients. We are interested in biopharma assets as well as innovative medical devices.

Geographically, we have a preference on US, Europe and China. Opportunities in other regions/countries will be considered on a case by case basis.